What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?

J Rheumatol. 2008 Oct;35(10):1903-5.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • B-Lymphocytes / immunology
  • Humans
  • Peptides, Cyclic / immunology*
  • Rheumatoid Factor / immunology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Peptides, Cyclic
  • Tumor Necrosis Factor-alpha
  • cyclic citrullinated peptide
  • Rheumatoid Factor